Philly-area developer Brian O’Neill to build cell and gene manufacturing facility in King of Prussia
Brian O’Neill, the Main Line developer who founded the substance-abuse treatment chain Recovery Centers of America, plans to develop a $1.1 billion cell and gene therapy manufacturing facility in King of Prussia.
The company, which O’Neill has named the Center for Breakthrough Medicines, is part of the Discovery Labs, a 1.6 million-square-foot, $500 million biotechnology, health-care, and life sciences office complex he is building in an industrial section of King of Prussia. The center will claim 680,000 square feet of the Discovery Labs.
The goal of the center, its management said Wednesday, is to pursue cures for diseases including cystic fibrosis, hemophilia A, and certain cancers by working with scientists, large pharmaceutical companies, and academic and governmental institutions…